Gene · 2145
Papers1,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging structural insights into PRC2 function in development and disease. | Trends Biochem Sci | 2026 | 41372031 | PubTator, text mining | PubMed |
| Telomere-protecting protein 1 promotes gastric cancer cell metastasis via enhancing endoplasmic reticulum stress. | J Biol Chem | 2026 | 41338460 | PubTator, text mining | PubMed |
| B-lineage commitment is dependent on a reversible epigenetic switch. | Genes Dev | 2026 | 41266087 | PubTator, text mining | PubMed |
| CD133-Guided RNA Nanoparticle Delivery of FTO siRNA Impairs Leukemia Resistance to Tyrosine Kinase Inhibitor Therapy. | RNA Nanomed | 2025 | 42004278 | PubTator, text mining | PubMed |
| [PINK1 suppresses colorectal cancer cell growth through epigenetic regulation of histone modifications]. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2025 | 41332108 | PubTator, text mining | PubMed |
| Malignant Potential of Thyroid Follicular Nodular Disease With Solid/Trabecular Components: A Case Report. | Pathol Int | 2025 | 41090246 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A/P-gp Modulators. | Clin Transl Sci | 2025 | 41078111 | PubTator, text mining | PubMed |
| Continuous DNA Methylation Deconvolution-Based Surrogate for B-Cell Differentiation State in CLL. | bioRxiv | 2025 | 41000815 | PubTator, text mining | PubMed |
| Dual EZH1/2 inhibition enhances DNMT inhibitor efficacy in colon cancer through targeting H3K27me1. | bioRxiv | 2025 | 41000734 | PubTator, text mining | PubMed |
| Identification of novel 2, 6-Di-substituted Imidazo[1,2-a]pyridine derivatives as potent METTL3 inhibitors. | Bioorg Chem | 2025 | 40961538 | PubTator, text mining | PubMed |
| Recent update on the development of EZH2 inhibitors and degraders for cancer therapy. | Eur J Med Chem | 2025 | 40884958 | PubTator, text mining | PubMed |
| Small-Molecule Drugs in Pediatric Neuro-Oncology. | Curr Oncol | 2025 | 40862786 | PubTator, text mining | PubMed |
| Exploiting an Epigenetic Resistance Mechanism to PI3 Kinase Inhibition in Leukemic Stem Cells. | bioRxiv | 2025 | 40791365 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| Culturing Potential: advances in ex vivo cell culture systems for haematopoietic cell-based regenerative therapies. | Regen Ther | 2025 | 40704043 | PubTator, text mining | PubMed |
| Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy Participants. | Clin Transl Sci | 2025 | 40622841 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
| Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open-Label, Phase I Study. | Clin Pharmacol Drug Dev | 2025 | 40366229 | PubTator, text mining | PubMed |
| H3F3A K27M mutations drive a repressive transcriptome by modulating chromatin accessibility independent of H3K27me3 in Diffuse Midline Glioma. | Epigenetics Chromatin | 2025 | 40287708 | PubTator, text mining | PubMed |
| Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia. | Blood Cancer J | 2025 | 40274779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2145/papers?page=2